Sign inGet started

DP VIII Associates, L.P.

Insider CIK 1465143 · GKOS 10% owner · OCRX 10% owner · LIFE 10% owner · VCYT 10% owner · SNDX 10% owner · DRNA 10% owner · BNGO 10% owner · OTIC 10% owner · DRTX 10% owner · ATRA 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
BNGO BioNano Genomics, Inc C Conversion deriv2018-08-232018-08-270— $00SEC↗
BNGO BioNano Genomics, Inc C Conversion deriv2018-08-232018-08-2727,328— $00SEC↗
BNGO BioNano Genomics, Inc C Conversion deriv2018-08-232018-08-2747,460— $00SEC↗
BNGO BioNano Genomics, Inc C Conversion deriv2018-08-232018-08-2740,268— $00SEC↗
BNGO BioNano Genomics, Inc C Conversion deriv2018-08-232018-08-2722,161— $00SEC↗
BNGO BioNano Genomics, Inc C Conversion deriv2018-08-232018-08-2750,532— $00SEC↗
BNGO BioNano Genomics, Inc C Conversion2018-08-232018-08-272,505$4.59 $11.5K6,891SEC↗
BNGO BioNano Genomics, Inc C Conversion2018-08-232018-08-274,386— $04,386SEC↗
DRNA Dicerna Pharmaceuticals In C Conversion deriv2017-12-182017-12-20368— $00SEC↗
DRNA Dicerna Pharmaceuticals In A Award2017-12-182017-12-20282— $025,730SEC↗
DRNA Dicerna Pharmaceuticals In C Conversion2017-12-182017-12-2012,444$3.19 $39.7K25,448SEC↗
OCRX Ocera Therapeutics, Inc. D To issuer2017-12-112017-12-137,333— $00SEC↗
DRNA Dicerna Pharmaceuticals In P Buy deriv2017-04-112017-04-12368$100.00 $36.8K368SEC↗
SNDX Syndax Pharmaceuticals Inc C Conversion deriv2016-03-082016-03-082,674— $00SEC↗
SNDX Syndax Pharmaceuticals Inc C Conversion deriv2016-03-082016-03-082,967— $00SEC↗
SNDX Syndax Pharmaceuticals Inc C Conversion2016-03-082016-03-085,641— $05,641SEC↗
GKOS GLAUKOS Corp C Conversion deriv2015-06-302015-07-014,371— $00SEC↗
GKOS GLAUKOS Corp C Conversion deriv2015-06-302015-07-012,130— $00SEC↗
GKOS GLAUKOS Corp C Conversion2015-06-302015-07-016,501— $06,501SEC↗
LIFE aTYR PHARMA INC C Conversion deriv2015-05-122015-05-1290,110— $00SEC↗
LIFE aTYR PHARMA INC C Conversion deriv2015-05-122015-05-1211,182— $00SEC↗
LIFE aTYR PHARMA INC C Conversion deriv2015-05-122015-05-126,581— $00SEC↗
LIFE aTYR PHARMA INC C Conversion2015-05-122015-05-1213,414— $013,414SEC↗
DRTX Durata Therapeutics, Inc. D To issuer2014-11-172014-11-1822,306— $00SEC↗
ATRA Atara Biotherapeutics, Inc C Conversion deriv2014-10-212014-10-219,443— $00SEC↗
ATRA Atara Biotherapeutics, Inc C Conversion deriv2014-10-212014-10-214,606— $00SEC↗
ATRA Atara Biotherapeutics, Inc C Conversion2014-10-212014-10-2114,049— $014,049SEC↗
ATRA Atara Biotherapeutics, Inc P Buy2014-10-212014-10-211,841$11.00 $20.3K15,890SEC↗
OTIC Otonomy, Inc. C Conversion deriv2014-08-182014-08-183,238— $00SEC↗
OTIC Otonomy, Inc. C Conversion deriv2014-08-182014-08-186,866— $00SEC↗
OTIC Otonomy, Inc. M Exercise deriv2014-08-182014-08-18502— $00SEC↗
OTIC Otonomy, Inc. F Tax w/h deriv2014-08-182014-08-181,386— $00SEC↗
OTIC Otonomy, Inc. F Tax w/h2014-08-182014-08-18277$16.00 $4.4K11,715SEC↗
OTIC Otonomy, Inc. C Conversion2014-08-182014-08-1811,490— $011,490SEC↗
OTIC Otonomy, Inc. M Exercise2014-08-182014-08-18502$8.79 $4.4K11,992SEC↗
DRNA Dicerna Pharmaceuticals In C Conversion deriv2014-02-042014-02-049,469— $00SEC↗
DRNA Dicerna Pharmaceuticals In C Conversion deriv2014-02-042014-02-04156— $00SEC↗
DRNA Dicerna Pharmaceuticals In C Conversion deriv2014-02-042014-02-04156— $0156SEC↗
DRNA Dicerna Pharmaceuticals In C Conversion deriv2014-02-042014-02-043,535— $00SEC↗
DRNA Dicerna Pharmaceuticals In C Conversion2014-02-042014-02-0413,004— $013,004SEC↗
VCYT VERACYTE, INC. C Conversion deriv2013-11-042013-11-0417,677— $00SEC↗
VCYT VERACYTE, INC. C Conversion deriv2013-11-042013-11-045,053— $00SEC↗
VCYT VERACYTE, INC. C Conversion2013-11-042013-11-0422,730— $022,730SEC↗
DRTX Durata Therapeutics, Inc. C Conversion deriv2012-07-242012-07-2416,529— $00SEC↗
DRTX Durata Therapeutics, Inc. C Conversion2012-07-242012-07-2416,529— $016,529SEC↗
DRTX Durata Therapeutics, Inc. P Buy2012-07-242012-07-245,777$9.00 $52.0K22,306SEC↗